[Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001960:Bromazepam / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy; D011413:Propantheline / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D004338:Drug Combinations; D011413:Propantheline; D001960:Bromazepam
Attività dell'associazione bromazepam-propantelina in pazienti con disturbi gastroenterici organici e funzionali.